Granulocyte colony-stimulating factor and an in vitro whole blood model of melioidosis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 23, Issue 3, 2004, Pages 205-207

  Cheng, A C ^a   Dasari, P ^a   Currie, B J ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; AUSTRALIA; BACTERICIDAL ACTIVITY; BLOOD; BURKHOLDERIA PSEUDOMALLEI; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; DISEASE MODEL; DRUG MECHANISM; HUMAN; IN VITRO STUDY; MELIOIDOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TROPICS;

AUSTRALIA; BURKHOLDERIA PSEUDOMALLEI; CASE-CONTROL STUDIES; COLONY COUNT, MICROBIAL; CULTURE MEDIA, CONDITIONED; DIABETES MELLITUS, TYPE 2; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; KIDNEY FAILURE, CHRONIC; MELIOIDOSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 1842638504     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-003-1088-y     Document Type: Article

References (15)

1. Cheng AC, Stephens DP, Anstey NM, Currie BJ (2004) Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis. Clin Infect Dis 38:32-37
2. Egan AM, Gordon DL (1996) Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes. Infect Immun 64:4952-4959
3. Jones AL, Beveridge TJ, Woods DE (1996) Intracellular survival of Burkholderia pseudomallei. Infect Immun 64:782-790
4. Hor LI, Chang TT, Wang ST (1999) Survival of Vibrio vulnificus in whole blood from patients with chronic liver diseases: association with phagocytosis by neutrophils and serum ferritin levels. J Infect Dis 179:275-278
5. Roilides E, Walsh TJ, Pizzo PA, Rubin M (1991) Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 163:579-583
6. Nelson S, Belknap SM, Carlson RW, Dale D, DeBoisblanc B, Farkas S, Fotheringham N, Ho H, Marrie T, Movahhed H, Root R, Wilson J (1998) A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community- acquired pneumonia. CAP Study Group. J Infect Dis 178:1075-1080
7. Nelson S, Heyder AM, Stone J, Bergeron MG, Daugherty S, Peterson G, Fotheringham N, Welch W, Milwee S, Root R (2000) A randomized controlled trial of filgrastim for the treatment of hospitalized patients with multilobar pneumonia. J Infect Dis 182:970-973
8. Root RK, Lodato RF, Patrick W, Cade JF, Fotheringham N, Milwee S, Vincent JL, Torres A, Rello J, Nelson S (2003) Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis. Crit Care Med 31:367-373
9. Pruksachartvuthi S, Aswapokee N, Thankerngpol K (1990) Survival of Pseudomonas pseudomallei in human phagocytes. J Med Microbiol 31:109-114
10. Razak N, Ismail G (1982) Interaction of human polymorphonuclear leukocytes with Pseudomonas pseudomallei. J Gen Appl Microbiol 28:509-518
11. Simpson AJH, Wuthiekanun V (2000) Interaction of insulin with Burkholderia pseudomallei may be caused by preservative. J Clin Pathol 53:159-160
12. Daschner FD, Grundmann H, Anding K, Lemmen S (1995) Combined effect of human neutrophils, ceftazidime and granulocyte colony-stimulating factor on killing of Escherichia coli. Eur J Clin Microbiol Infect Dis 14:536-539
13. Weiss M, Moldawer LL, Schneider EM (1999) Granulocyte colony-stimulating factor to prevent the progression of systemic nonresponsiveness in systemic inflammatory response syndrome and sepsis. Blood 93:425-439
14. Powell K, Ulett G, Hirst R, Norton R (2003) G-CSF immunotherapy for treatment of acute disseminated murine melioidosis. FEMS Microbiol Lett 224:315-318
15. Turzanski J, Crouch SP, Andrews M, Rose M, Finch R, Burden R, Holliday M, Fletcher J (1998) Effects of r-metHuG-CSF on polymorphonuclear leucocyte kinetics and function in patients on continuous ambulatory peritoneal dialysis. Br J Haematol 103:387-396